Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis

Background: This meta-analysis assessed the safety and effectiveness of retreatment with trastuzumab in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (HER2+MBC). Materials and methods: Randomized controlled trials (RCTs) and cohort studies that compa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Manag Res
Egile Nagusiak: Han, Yiqun, Wang, Jiayu, Liu, Weiming, Yuan, Peng, Li, Qing, Zhang, Pin, Ma, Fei, Luo, Yang, Fan, Ying, Chen, Shanshan, Cai, Ruigang, Li, Qiao, Xu, Binghe
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove 2019
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536717/
https://ncbi.nlm.nih.gov/pubmed/31213894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S198962
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak